Benefits
Testosterone support in middle-aged men (foundational trial)
The 2016 Andrologia RCT in 75 healthy men aged 45-55 showed PrimaVie® at 500 mg/day for 90 days increased total testosterone ~20%, free testosterone ~19%, and DHEAS significantly versus placebo. Foundational evidence for the testosterone-support positioning — most-cited clinical trial in the shilajit space.
Sperm count and male fertility
A trial in 60 infertile men showed PrimaVie® at 200 mg twice daily for 90 days significantly increased total sperm count, sperm motility, and serum testosterone. Mechanism likely involves both Leydig cell support and antioxidant protection of sperm cells.
Muscle strength preservation during training
A trial published in Journal of the International Society of Sports Nutrition showed PrimaVie® supplementation supported muscle strength and exercise tolerance in physically active men. Effect sizes modest but consistent with the testosterone and mitochondrial mechanisms.
Mitochondrial energy and CoQ10 potentiation
PrimaVie® DBPs function as mitochondrial electron carriers that may enhance ATP production. Animal studies show PrimaVie® combined with CoQ10 produces greater energy effects than CoQ10 alone — suggesting potentiation of mitochondrial cofactor function. Human evidence is preliminary but mechanistically supported.
Cognitive support (preliminary)
Fulvic acid inhibits tau protein aggregation in cell models, with potential relevance to neurodegenerative disease. PrimaVie® has been investigated for cognitive function support in older adults, though human cognitive evidence remains preliminary.
FDA GRAS status and safety certification
PrimaVie® has FDA Generally Recognized as Safe (GRAS) status — established before DSHEA 1994. Vegetarian, kosher, and halal certified. Long-term safety established up to 500 mg/day for 48 weeks in clinical trials. Important distinction from generic shilajit products that may carry heavy metal contamination.
Purification advantage over generic shilajit
Raw unprocessed shilajit can contain heavy metals (lead, arsenic, mercury), mycotoxins, and free radicals. PrimaVie®'s patented purification process specifically addresses these contaminants while preserving bioactive content. The processing advantage is mechanism-relevant, not just marketing — quality of purification determines whether shilajit is therapeutic or harmful.
Reproducible standardization
PrimaVie® provides documented composition (≥60% bioactives) batch-to-batch via HPLC quantification. Generic shilajit products vary dramatically in actual bioactive content, even when labels claim similar amounts. Standardization is what enables consistent clinical effects across published trials.
Mechanism of action
Leydig cell support for testosterone production
PrimaVie® appears to enhance Leydig cell function, increasing testosterone production at the gonadal level. Notably, the foundational trial showed stable LH and FSH — meaning effects are mediated at the testicular level rather than disrupting the HPA axis. Distinguishing from medications or compounds that disrupt hypothalamic-pituitary feedback.
Mitochondrial electron transport via DBPs
Dibenzo-α-pyrones in PrimaVie® function as mitochondrial electron carriers, potentially enhancing electron transport chain efficiency and ATP production. Mechanism explains the energy support and CoQ10 potentiation effects.
Fulvic acid mineral chelation and absorption
Fulvic acid's chelating structure binds minerals and may enhance their transport across cell membranes. Mechanism contributes to the mineral absorption benefits and may explain hemoglobin/ferritin improvements in anemic populations.
Antioxidant activity
PrimaVie® components scavenge reactive oxygen species and support glutathione synthesis. The antioxidant mechanism may underlie the muscle recovery benefits and the sperm motility improvements in fertility trials — both contexts where oxidative damage is mechanistically relevant.
Clinical trials
A 90-day randomized double-blind placebo-controlled trial in 75 healthy men aged 45-55 showed PrimaVie® at 500 mg/day increased total testosterone ~20%, free testosterone ~19%, and DHEAS significantly.
75 healthy men aged 45-55
A 90-day randomized double-blind placebo-controlled trial in 75 healthy men aged 45-55 showed PrimaVie® at 500 mg/day increased total testosterone ~20%, free testosterone ~19%, and DHEAS significantly. Published in Andrologia. The most-cited shilajit clinical trial in modern research.
A 90-day trial in 60 infertile men showed PrimaVie® at 400 mg/day increased total sperm count, sperm motility, and serum testosterone significantly.
Clinical population described in trial publication.
A 90-day trial in 60 infertile men showed PrimaVie® at 400 mg/day increased total sperm count, sperm motility, and serum testosterone significantly. Supports the broader male reproductive health positioning beyond pure testosterone effects.
Multiple trials in physically active men using PrimaVie® show muscle strength preservation during training and mitochondrial energy improvements.
Clinical population described in trial publication.
Multiple trials in physically active men using PrimaVie® show muscle strength preservation during training and mitochondrial energy improvements. Published in Journal of the International Society of Sports Nutrition and similar peer-reviewed outlets.
Clinical trials up to 48 weeks at 500 mg/day show no significant adverse events with PrimaVie®.
Clinical population described in trial publication.
Clinical trials up to 48 weeks at 500 mg/day show no significant adverse events with PrimaVie®. Heavy metal levels remained within safety thresholds throughout extended supplementation — validating the purification process safety claims.